Drugmaker GSK says first quarter revenue dropped 2 percent

Pharmaceutical and consumer goods maker GlaxoSmithKline says first-quarter revenue dropped 2 percent as a stronger pound offset encouraging sales of a new shingles treatment.

The company said in a statement Wednesday that revenue rose to 7.22 billion pounds ($10.1 billion) from 7.38 billion pounds in the same period last year. Net income fell 48 percent to 549 million pounds as GSK took a 495 million pound charge related to the revaluation of the consumer healthcare business after it agreed to acquire full ownership of the .

Sales of the shingles treatment Shingrix totaled 110 million pounds in its first full quarter on the market.

CEO Emma Walmsley says GSK's main priority is to strengthen the pharmaceuticals business and the pipeline of drugs under development.

Explore further

GSK sees rise in sales of vaccines, healthcare products

© 2018 The Associated Press. All rights reserved.

Citation: Drugmaker GSK says first quarter revenue dropped 2 percent (2018, April 25) retrieved 17 January 2022 from https://medicalxpress.com/news/2018-04-drugmaker-gsk-quarter-revenue-percent.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors